Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Effect of fish oil supplementation in pregnancy on bone, lean, and fat mass at six years: randomised clinical trial

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Quality of dietary fat and genetic risk of type 2 diabetes: individual participant data meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Viagra for fetal growth restriction: STRIDER Consortium replies to letter by Symonds and Budge

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Association of Birth Weight With Type 2 Diabetes and Glycemic Traits: A Mendelian Randomization Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Neonatal Urine Metabolic Profiling and Development of Childhood Asthma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Optimal timing of influenza vaccine during pregnancy: A systematic review and meta-analysis

    Research output: Contribution to journalReviewResearchpeer-review

  4. Fish-oil supplementation in pregnancy, child metabolomics and asthma risk

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. A Protocol for Extraction of Infective Viromes Suitable for Metagenomics Sequencing from Low Volume Fecal Samples

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: To examine the effect of supplementation with n-3 long chain polyunsaturated fatty acids (n-3 LCPUFA) in pregnancy on anthropometry and body composition in offspring.

DESIGN: Double blinded, randomised controlled trial.

SETTING: Copenhagen Prospective Studies on Asthma in Childhood2010 cohort.

PARTICIPANTS: 736 pregnant women and their offspring.

INTERVENTION: n-3 LCPUFA (fish oil) or control (olive oil) daily from pregnancy week 24 until one week after birth.

MAIN OUTCOME MEASURES: Height/length, weight, head, and waist measurements and body composition from dual energy x ray absorptiometry (all pre-specified secondary endpoints of the n-3 LCPUFA trial; the primary outcome for the trial was persistent wheeze/asthma).

RESULTS: The mean body mass index (BMI) z score was increased between age 0 and 6 years in the fish oil supplementation group compared with the control group (0.14 (95% confidence interval 0.04 to 0.23); P=0.006). At 6 years, supplementation was associated with a higher BMI z score (0.19 (0.06 to 0.32); P=0.004), a higher weight/height (3.48 (0.38 to 6.57) g/cm; P=0.03), and a larger waist circumference (0.6 (0.0 to 1.2) cm; P=0.04) but not a higher proportion of obese children, using International Obesity Task Force grades. The dual energy x ray absorptiometry scan at age 6 years showed a higher total mass (395.4 (86.6 to 704.3) g; P=0.01) in the supplementation versus the control group, explained by a higher lean mass (280.7 (98.9 to 462.4) g; P=0.002), a higher bone mineral content (10.3 (2.3 to 18.1) g; P=0.01), and a non-significantly higher fat mass (116.3 (-92.9 to 325.5) g; P=0.28), but no differences were seen in total body fat or lean mass percentage.

CONCLUSION: Fish oil supplementation from the 24th week of pregnancy led to a higher BMI in the offspring from 0 to 6 years of age but not an increased risk of obesity at age 6. The body composition at age 6 years in children given fish oil supplementation was characterised by a proportional increase in lean, bone, and fat mass suggesting a general growth stimulating effect of n-3 LCPUFA.

TRIAL REGISTRATION: Clinicaltrials.gov NCT00798226.

Original languageEnglish
JournalBMJ
Volume362
Pages (from-to)k3312
ISSN1756-1833
Publication statusPublished - 4 Sep 2018

ID: 55159848